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Abstract
Background: The goal of cardiac rehabilitation programs is not only to prolong life but also to improve physical
functioning, symptoms, well-being, and health-related quality of life (HRQL). The aim of this study was to
document the long-term effect of a 1-month inpatient cardiac rehabilitation intervention on HRQL in Austria.
Methods: Patients (N = 487, 64.7% male, age 60.9 ± 12.5 SD years) after myocardial infarction, with or without
percutaneous interventions, coronary artery bypass grafting or valve surgery underwent inpatient cardiac
rehabilitation and were included in this long-term observational study (two years follow-up). HRQL was
measured with both the MacNew Heart Disease Quality of Life Instrument [MacNew] and EuroQoL-5D [EQ-
5D].
Results: All MacNew scale scores improved significantly (p < 0.001) and exceeded the minimal important
difference (0.5 MacNew points) by the end of rehabilitation. Although all MacNew scale scores deteriorated
significantly over the two year follow-up period (p < .001), all MacNew scale scores still remained significantly
higher than the pre-rehabilitation values. The mean improvement after two years in the MacNew social scale
exceeded the minimal important difference while MacNew scale scores greater than the minimal important
difference were reported by 40-49% of the patients.
Two years after rehabilitation the mean improvement in the EQ-5D Visual Analogue Scale score was not
significant with no significant change in the proportion of patients reporting problems at this time.
Conclusion: These findings provide a first indication that two years following inpatient cardiac rehabilitation in
Austria, the long-term improvements in HRQL are statistically significant and clinically relevant for almost 50% of
the patients. Future controlled randomized trials comparing different cardiac rehabilitation programs are needed.
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Background
Besides prolonging life, the objectives of cardiac rehabili-
tation (CR) include the reduction of symptoms and the
improvement of physical functioning and general wellbe-
ing [1,2]. These outcomes are typically considered to be
patient-reported outcomes (PRO) and have top-tier prior-
ity when it comes to assessing quality in cardiovascular
care [3]. A recently published meta-analysis showed that
12 out of 12 exercise-based outpatient CR programs
improved health-related quality of life (HRQL) but the
magnitude of improvement in HRQL with cardiac reha-
bilitation exceeded that of the controls in only two trials
[4].
There is a great variety of CR programs in the different
European countries with either inpatient or outpatient
(including home-based CR [5]) or both CR programs
available for patients [6]. A wide range of patients having
undergone different interventions (e.g. percutaneous cor-
onary intervention (PCI) and coronary artery bypass graft-
ing (CABG) or heart valve surgery (HVS)) and presenting
various diagnoses (myocardial infarction (MI), angina or
heart failure (HF)) are eligible for these programs which
makes it difficult to compare PROs. Inpatient as well as
outpatient CR programs are provided in Austria [7] and
there is evidence from a non-randomized study that both
types of CR programs adequately improve the short term
(3-month) outcome of HRQL [8]. In addition, short-term
studies including PRO and clinical data for the major six
Austrian cardiac inpatient rehabilitation centers have doc-
umented statistically significant and clinical important
improvements in HRQL and reduction of risk factors in an
unselected patient group [9].
Although the Austrian legal framework makes it manda-
tory that the health care systems and their long-term ben-
efits are evaluated from a patient-centered perspective
(Gesundheitsqualitätsgesetz BGBL I Nr. 179/2004), there
is little or no data available regarding the long-term (>12
months) effects of inpatient CR programs on HRQL [10].
Further, the question about which particular sub-group
within the population of eligible patients enjoys the great-
est benefits from these programs within a particular time-
frame and in accordance with national [11,12] or
international guidelines [13] has not been answered. The
aim of this study was therefore to document the long-term
PRO improvements of the inpatient CR programs availa-
ble in Austria.
Methods
Over a period of 8 weeks in 2004, 487 consecutive
patients after MI, angina or heart valve disease with or
without PCI, CABG or heart valve surgery in six cardiac
rehabilitation centers managed by the Austrian Pension
Insurance Institution ("Pensionsversicherungsanstalt" or
"PVA") were included in this observational study. Patients
completed the 4-week inpatient CR program as soon as
possible after initial treatment. A detailed description of
the CR program has been published and the selected
patient group constitutes a representative sample of the
participants in the inpatient CR programs available in
Austria [9]. The protocol was approved by the institu-
tional review board of the Austrian Pension Insurance
Institution.
Baseline data were collected at the beginning (pre rehabil-
itation, t0) and at the end of the 4 week inpatient CR (post
rehabilitation, one month t1) [9]. The two year follow-up
was performed as a postal follow-up (t2). The mailed
package included a prepaid return envelope with the two
questionnaires used at baseline, the MacNew Heart Dis-
ease Health-related Quality of Life Instrument [MacNew]
and the EuroQol 5D [EQ-5D] plus a list of major adverse
cardiac events. One postal reminder was sent out if
patients did not return the initial questionnaire.
MacNew
The MacNew is an internationally well documented valid
and reliable instrument to assess HRQL for patients with
different manifestations of heart disease, such as angina
pectoris [14], myocardial infarction [15], heart failure
[16], and arrhythmia [17] as well as different interven-
tions (such as PCI, CABG [18], pacemaker implant [19] or
CR [5,8,20]). Currently the MacNew is the only interna-
tional disease-specific HRQL instrument that ensures a
reliable and valid assessment and comparison of cardio-
vascular patients with varying presentations and symp-
toms of their disease.
The MacNew comprises 27 items which are scored from 1
(poor HRQL) to 7 (high HRQL) and consists of three
scales: physical limitations, emotional function, and
social function; additionally an overall HRQL score can be
calculated [21]. Reference data are available for different
diagnostic entities and age groups [22]. The minimal
important difference (MID; knowledge of the smallest
change in instrument score that patients perceive as
important [23]) for a MacNew change score has been
established to be 0.5 MacNew points [22].
EQ-5D
The EQ-5D is a generic instrument for the measurement
of HRQL and therefore particularly suited for compari-
sons with other diseases (e.g. cancer). On the basis of the
utility approach, the EQ-5D can be used to calculate qual-
ity adjusted life years (QALYs) [24]. The EQ-5D consists of
a 5-dimensional descriptive system and a visual analogue
scale allowing assessment of relevant segments of HRQL:Health and Quality of Life Outcomes 2009, 7:99 http://www.hqlo.com/content/7/1/99
Page 3 of 10
(page number not for citation purposes)
mobility, self-care, usual activities, pain/discomfort, and
anxiety/depression. The EQ-5D has repeatedly been used
and was validated with the aid of the MacNew in German-
speaking CHD patients with acceptable psychometric
properties (test-retest reliability and responsiveness) [25].
Major adverse cardiac events
The patients were queried whether and when the follow-
ing major adverse cardiac events had occurred in the last
two years: 1) heart attack, 2) symptoms of angina, 3)
bypass surgery, 4) valve replacement, and 5) coronary
intervention. In addition, the patients were asked if they
had participated in other rehabilitation interventions
such as another inpatient rehabilitation program or a fol-
low-up outpatient rehabilitation program. Death as a
major adverse cardiac event was recorded with the help of
the Austrian health information system.
Statistical analysis
Descriptive procedures (means, standard deviation, fre-
quencies) were used to describe patient characteristics. To
compare responders with non-responders independent t-
test and chi-square were used. Paired t-test (MacNew) and
Wilcoxon (EQ-5D) test were applied to check the statisti-
cal significance for time and analysis of variance for group
comparisons.
Effect sizes for the comparison baseline/follow-up were
calculated (ES = (M1-M2)/SD1). Values between 0.20 and
< 0.50 are considered as small, values between 0.50 and <
0.80 as moderate and ≥ 0.80 as high [26]. The significance
level was established at p < 0.05. All analyses were con-
ducted using the statistics software package SPSS 16 for
Windows (SPSS Incorp., USA).
Results
Questionnaires were returned by 351 patients (mean age
of 60.9 ± 12.5 years, 66% males, completion rate of
72.1%, Table 1). Additional selected baseline socio-
demographic and clinical variables for all responders and
non-responders are given in Table 1. Reasons for not
returning the questionnaires included death (14.7%),
incorrect address (5.2%), and unknown (80.1%). Com-
pared to responders, non-responders were 2.5 times more
likely to have been working at baseline (Table 1). Based
on the other available variables no significant difference
between responders and non-responders could be
detected.
During the two year follow-up, major adverse cardiac
events among the 487 patients were recorded on 140
occasions. It included 20 deaths (4.1%) with angina the
most frequent event (11.9%, Table 2). A single major
adverse cardiac event was recorded for 76 patients while
21 patients reported more than one.
There was a significant short-term improvement in all
MacNew HRQL scales over the one-month inpatient CR
program (Table 3, and [9]) with fewer patients (p < 0.001)
reporting problems on the EQ-5D mobility, daily activi-
ties and pain/discomfort sub-scales at the end of inpatient
CR (Table 7 in [9]). It is important to note that both
responders and non-responders reported the same initial
improvement in all MacNew and EQ-5D HRQL scale
scores after CR (global: p = .622; physical: p = .948; emo-
tional: p = .377; social: p = .711, mobility; p = .784; self-
care: p = .881; daily activities: p = .451; pain: p = .655; anx-
iety/depression: p = .293).
Over the two year period following the end of inpatient
rehabilitation program, HRQL significantly decreased in
all MacNew scales (e.g., global MacNew, Figure 1). How-
ever, at the two year follow-up the mean HRQL for all
MacNew scale scores were still significantly higher than at
baseline with the social HRQL on average still above the
MID of 0.5 MacNew points (change in global HRQL: 0.33
p = < .001; physical HRQL: 0.35 p = < .001; emotional
HRQL: 0.24 p = .003; social HRQL: 0.52 p = < .001).
Although 43.0% [n = 151] of the patients reported an
improvement in HRQL over the two-year follow-up that
was equal to or exceeded the MID of 0.5 points, the effect
sizes were small two years after inpatient CR (Table 3).
On the basis of the MacNew MID, the responders were
then grouped as having a negative (-0.5 MacNew points),
unchanged [-0.49-0.49 MacNew points) or positive [+0.5
MacNew points] MID (Table 3). About 25% of the
patients reported either a clinically important deteriora-
tion or remained unchanged with between 40 and 49% of
the patients reporting a clinically important improvement
on the MacNew HRQL scale scores. Moreover, patients
who reported an improved HRQL of greater than the MID
two years after CR had initially reported an improvement
of 1.12 MacNew points with CR. This initial improvement
was significantly higher (p < 0.001) than that reported by
either those whose HRQL had deteriorated within two
years (initial improvement = 0.38 MacNew points) or
those whose HRQL remained unchanged over two years
(initial improvement = 0.42 MacNew points).
On the basis of the change in MacNew global HRQL, the
effect sizes and the proportion of patients exceeding the
MacNew MID of 0.5 points were calculated for the
responders in accordance with the main diagnosis, the
pre-treatment, the risk profile, and the socio-demographic
status (age groups and gender) (Additional file 1; Table
S1). HRQL improved at two years in patients with ischae-
mic heart disease (p < 0.002) with a medium effect size of
0.65 and an improvement greater than the MID in 43.5%;
HRQL also improved in patients with heart valve disease
(p = 0.011) with a small effect size of 0.42 and anHealth and Quality of Life Outcomes 2009, 7:99 http://www.hqlo.com/content/7/1/99
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improvement greater than the MID in 49%. As far as the
treatment before CR is concerned, HRQL improved over
the two years in patients with CABG and HVS (p < 0.001)
with medium effect sizes of 0.60 and 0.64, respectively,
and an improvement greater than the MID in 58.4% of
the patients after CABG and in 60.6% of patients having
undergone HVS.
Patients without hypertension, without diabetes or with-
out hypercholesterolemia improved their HRQL (p <
0.001) at two years with a small (no diabetes, ES = 0.38)
or medium effect sizes (no hypertension, ES = 0.64; no
hypercholesterol, ES = 0.56) and an improvement greater
than the MID two years after CR in 48-56% of the
patients. Patients with no major adverse cardiac event in
the last two years reported on average a medium effect,
with 51% having a long lasting effect. In contrast, patients
with one or more major adverse cardiac events deterio-
rated on average by 0.3 MacNew points. It is interesting to
note that these patients had already initially (t0) low
Table 1: Clinical- and socio-demographic patient characteristics of responders and non-responders (N = 487)
Responder Non-responder
Variable Categories M ± SD N % M ± SD N % p-value
Age 60.9 ± 12.5 59.2 ± 13.5 0.08$
Gender Male 232 66.1% 95 70.8%
Female 119 33.9% 41 29.2%
Total 351 100% 136 100% 0.33§
Professional status Employed 43 12.3% 42 30.9%
Retired 260 74.1% 63 46.3%
Unemployed 9 2.6% 4 2.9%
Other 25 7.1% 10 7.4%
Total 337 96.0% 119 87.5%
Missing 14 4.0% 17 12.5% 0.08§
Education Compulsory education (CE) 101 28.8% 34 25.0%
CE+ vocational training 135 38.5% 54 39.7%
University degree 89 25.4% 32 23.5%
Total 325 92.6% 120 88.2%
Missing 26 7.4% 16 11.8% 0.45§
Smoking status Current 39 11.1% 11 8.1%
Ex-smoker 165 47.0% 69 50.7%
Never smoker 119 33.9% 34 25%
Total 323 92.0% 114 83.8
Missing 28 8.0% 22 16.2% 0.34§
Primary diagnosis Ischemic heart disease 271 77.2% 109 80.1%
Heart valve disease 51 14.5% 13 9.6%
Other 29 8.3% 14 32.6% 0.30§
Primary intervention PCI 170 48.4% 63 46.3%
CABG 102 29.1% 39 28.7%
HVS 54 15.4% 18 13.2%
OPT 25 7.1% 16 11.8% 0.77§
NYHA# I 328 93.4% 118 86.8%
(at discharge of initial CR) II 19 5.4% 16 11.8%
III 4 1.1% 2 1.5% 0.05§
IV - -
PCI = percutaneous coronary intervention
CABG = coronary artery bypass grafting
HVS = heart valve surgery
OPT = optimal pharmacological treatment
# New York Heart Association Classification
$independent t-test
§chi-squareHealth and Quality of Life Outcomes 2009, 7:99 http://www.hqlo.com/content/7/1/99
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HRQL scale scores (p < 0.001). Two years after CR, HRQL
improved (p < 0.001) in male but not in female patients,
although the effect size was rather small (ES = 0.37)
despite the fact that 48% of the males reported an
improvement greater than the MID.
Compared with mid-age (41-65) and older (>65) patients
the young (<41) showed strong effects, that were long
lasting in 62% of the cases; although statistically signifi-
cant effects could be shown for the age groups 41 and
older, in terms of effect statistics there were no (age group
41-65) or small effects (age group 65+), with long lasting
effects for 43-40% of the patients.
Beyond the often long lasting improvements in disease-
specific HRQL, no long-term improvements were
observed in "mobility", "self-care" and "pain" as meas-
ured by the generic EQ-5D. The ability to perform usual
daily life activities remained 6% higher two years after CR.
However a considerable proportion of patients (7%
increase) reported some problems with "anxiety/depres-
sion" two years after CR (Table 4). The overall subjective
health status based on the EQ-5D VAS Scale returned to
baseline level (65.0).
Discussion
In this study, although mean HRQL decreased over the
two years following CR in the 351 patients referred to the
six participating Austrian inpatient rehabilitation centers,
all MacNew scale scores HRQL remained significantly
higher than at baseline with the mean social HRQL
change greater than the MID of 0.5 MacNew points. An
additional indication for the positive long-term results of
inpatient CR can be seen in the fact that as many as 60.1%
of the patients reported an improved global MacNew
HRQL score with 43.0% achieving or exceeding the MID.
Comparing our results to published norm data, baseline
HRQL values were below, t1 HRQL values were higher
and t2 HRQL values were comparable to published norm
values [22].
More detailed analyses made it possible to identify sub-
groups of patients who benefit most from the programs
offered by the PVA inpatient CR centers in Austria. The
improvement in HRQL showed greater effect sizes for
patients with ischemic heart disease than for patients with
valvular disease. Patients having undergone surgery
(either CABG or HVS) prior to rehabilitation benefited
more than patients after PCI which may be a consequence
Table 2: Major Adverse Cardiac Events in the last two years post cardiac rehabilitation
Major Adverse Cardiac Event Frequency N Percentage %
Death (all-cause mortality) 20 4.1%
Myocardial infarction 10 2.1%
Recurring angina 68 11,9%
CABG 8 1.6%
Heart valve surgery 8 1.6%
Coronary intervention (incl. stinting) 26 5.3%
Total 140 28.7%
Multiple major adverse cardiac events in 21 patients
Table 3: Mean change [M; 95% Confidence Interval (95% CI)] scores in MacNew HRQL, effect size statistics [ES; t0-t2] and minimal 
important difference [MID; t0-t2] over time
t0-t1 t1-t2 t0-t2 Deterioration
- MID [-0.5]
Unchanged
no change
= MID
Improvement
+ MID [0.5+]
MacNew N M 95% CI p-value$ M 95% CI p-value$ ES N % N % N %
Global 340 0.7 0.60 - 0.85 <0.001 -0.4 -0.60 - -0.23 <0.001 0.28 86 24.5 99 28.2 151 43.0
Emotional 320 0.6 0.49 - 0.76 <0.001 -0.4 -0.61 - -0.19 <0.001 0.20 80 22.8 94 26.8 139 39.6
Physical 339 0.9 1.0 - 0.70 <0.001 -0.5 -0.72 - - 0.33 <0.001 0.26 102 29.1 83 23.7 150 42.7
Social 338 0.8 0.67 - 0.98 <0.001 -0.3 -0.55 - -0.13 <0.001 0.40 85 24.2 77 21.9 171 48.7
t0: baseline, pre rehabilitation
t1: post rehabilitation, one month
t2: two years follow-up
ES: effect size statistics from t0 to t2
MID: minimal important difference from t0 to t2 [MID = 0.5 MacNew points]
$paired t-testHealth and Quality of Life Outcomes 2009, 7:99 http://www.hqlo.com/content/7/1/99
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of the particular positive effect of the PCI that makes these
patients report the greatest improvements in HRQL after a
PCI but before rehabilitation [27]. This observation ques-
tions the additional benefit of inpatient CR as an oppor-
tunity for further improvement of HRQL in this patient
group. This is in line with previous findings which have
shown that CR is especially beneficial to CABG patients
12 months after CR (effect sizes i.e. 0.66 after 12 months)
[10].
The management of patients with risk factors, i.e., smok-
ing, hypertension, diabetes mellitus or hypercholestero-
lemia, where no long-term effects of statistical or clinical
significance were observed, is a more challenging task.
This raises the question whether it is possible to better
manage patients at risk by providing additional on-going
support (i.e. outpatient programs, long-term monitoring
via modern media - eHealth) with the aim that this would
bring about a potentially long-term benefit for these high
risk patients.
The results of this study also suggest that younger patients,
with an effect size of 0.91, derive the greatest long-term
benefit from inpatient CR in terms of an improved HRQL
(with 63% having a long-lasting effect). This is partly in
line with previous findings, where increased age (65+)
was associated with mental HRQL comparable to commu-
nity norms [28] or with a greater improvement after CR
[10]. Our results, however, indicate that there is a U-form
type of relationship. Either patients <41 or patients 65+
years old reported small to medium effect sizes, with no
effects for the age group 41-65. Finally, the fact that male
Change in mean global MacNew HRQL over time Figure 1
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patients show a greater benefit than female ones may sug-
gest a possible programmatic gender issue which needs
further investigation.
The 5 dimensions of HRQL as measured by the generic
EQ-5D did show improvements for daily activities for a
small proportion of patients (6%). However, in contrast
to the disease-specific significant MacNew HRQL changes,
the EQ-5D did not pick up an overall global health status
improvement for the whole group, with values returning
to pre-rehabilitation levels. This is in line with previous
research demonstrating that disease specific instruments
are more sensitive to change in contrast to generic HRQL
instruments which are more useful when comparing dif-
ferent diagnoses [29]. Another important and more gen-
eral finding is the reported increase in anxiety/depression
two years after the end of the inpatient CR program. Since
there is presently a controversial discussion about depres-
sion as a potential risk factor or a significant comorbidity
[30-32] influencing the outcome [33], special attention
needs to be paid to the diagnosis of anxiety/depression in
patients attending inpatient CR [34].
Although patients with one or more major adverse cardiac
events two years after CR reported the same initial
improvement of 0.7 MacNew points as patients without
major adverse cardiac events in the follow-up period, their
initial HRQL scale scores were significantly lower (<4.5
MacNew points) which means that the difference between
the two groups was close to the MID of 0.5 MacNew
points. Low HRQL has been shown to have negative
effects on adherence [35], and adherence itself is a highly
relevant factor for health outcomes (e.g. [36,37]). In addi-
tion, a previous study using the MacNew scale scores pre-
dicted adverse cardiac events including death [38]. This
corroborates the findings of the present study suggesting
that initial screening for HRQL, especially at the begin-
ning of CR, may be a potential decision-making tool, to
improve the identification of high risk patients. An inten-
sive monitoring of high risk patients is advisable (i.e. with
low initial HRQL: <4.5 MacNew points at the beginning
of CR; or little HRQL improvement: <0.5 MID improve-
ment) after the end of CR in order to prevent possible
future major adverse cardiac events. Future studies and
programs should address the benefit of ongoing brief con-
Table 4: EQ-5D generic HRQL at baseline (t0), one month (t1) and two years (t2) (percentage %)
Timepoint
t0 t1 t2 Z p-value [t0-t2]
EQ-5D Dimensions
Mobility (N = 291)
No problems 71.3% 83.2% 72%
Some problems 28.7% 16.3% 27.4%
Severe problems 0% 0.5% 0.6% .630 .529$
Self care (N = 293)
No problems 90.5% 93.7% 87.4%
Some problems 8.4% 4.5% 10.9%
Severe problems 1.1% 1.8% 1.8% 1.376 .169$
Daily activities (N = 290)
No problems 58.3% 64.0% 64.3%
Some problems 32.5% 30.6% 31.1%
Severe problems 9.2% 5.4% 4.6% 1.999 .046$
Pain (N = 291)
No problems 29.0% 40.8% 32.4%
Some problems 65.5% 55.2% 60.9%
Severe problems 5.5% 4.1% .8% .865 .387$
Anxiety/depression (N = 291)
No problems 65.9% 68.9% 60.9%
Some problems 31.0% 28.6% 35.8%
Severe problems 3.1% 2.6% 3.3% 2.167 .030$
VAS
Median (N = 263) 66.0 75.0 70.0
Mean (N = 208) 63.7 ± 17.6 73.4 ± 17.6 65.0 ± 20.4 .931#
VAS Visual Analogue Scale
# T-test
$Wilcoxon-Test
t0: baseline, pre rehabilitation
t1: post rehabilitation, one month
t2: two years follow-upHealth and Quality of Life Outcomes 2009, 7:99 http://www.hqlo.com/content/7/1/99
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tacts with patients having undergone CR with the aim of
monitoring their health status with the help of modern
eHealth technologies.
The amount of publications addressing PROs such as
HRQL after inpatient cardiac rehabilitation is very lim-
ited. Published articles addressing inpatient cardiac reha-
bilitation primarily focus on cost analysis [39],
cardiovascular risk factors [40,41], consumer parameters
(such as treatment satisfaction or patient expectations
[42,43]) or its utilization [44,45]. In this study we docu-
mented the long-term (two years) HRQL outcome of
patients following a one month inpatient CR. If HRQL has
been used as an outcome parameter in cardiac rehabilita-
tion evaluation studies a variety of measures have been
used making outcome comparisons difficult [46]. For
example Müller-Nordheim used in a similar study the
generic SF-36 with a one year follow-up period. The gen-
eral findings are comparable to ours, with large effect size
HRQL improvements for patients after CABG, less after
PCI and non after MI [10]. In contrast to our results,
women reported more frequently improvements in health
status then men. Overall, a consistent application of a sin-
gle core heart disease specific HRQL outcome measure to
allow program comparisons is warranted.
A major limitation of this study is the lack of a control
group, which does not allow attributing the documented
improvement in HRQL only to CR. As there is no evidence
for the natural history of long-term recovery of patients
not attending CR in Austria, it is difficult to distinguish
the effect of CR from other factors. Further, although there
is relatively little documentation of the long-term benefits
of inpatient CR, it is a clinically well-established practice
in Austria making the feasibility of randomization to a
control versus an inpatient CR group questionable. In
relation to this, a study by Benzer et al. comparing inpa-
tient CR, outpatient CR and usual care (non-CR partici-
pants) over a short period of time indicated that there is a
faster recovery of HRQL for CR attendees in contrast to no
CR [8]. However the question of whether and how CR
non-participants improve over a long term period such as
two years remains unanswered and future evaluation
projects need to consider the possibility of control groups
at least for short-term outcomes (i.e. waiting-list con-
trols). Further, the HRQL of non-responders (27.9%)
remains unclear. It should be noted, however, that the
analyses of non-responders and responders did not sug-
gest that there was a selection bias based on the available
variables, or the initial HRQL improvements. Another
limitation of this study is the lack of information about
stroke as an additional major cardiac event.
This study documented improved HRQL for as many as
49% of all patients two years after CR, complementing the
available literature on long term health outcomes after
inpatient CR. In particular male patients up to 41 years
with either ischemic heart disease or pre-treated with
CABG or HVS and without risk factors benefited most
from the existing CR programs. It may, therefore, be nec-
essary to develop gender- and age-specific modules.
HRQL screening for high risk patients (low HRQL) com-
bined with a long term monitoring should be applied to
minimize major cardiac events in high risk patients.
Future controlled randomized trials comparing different
cardiac rehabilitation programs using a single core heart
disease specific PRO outcome measure are needed.
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